This content is machine translated Psoriasis and metabolic comorbidities: new study data GLP-1RAs showed a valuable dual benefit GLP-1RAs, including semaglutide and liraglutide, are frequently used today for the treatment of type 2 diabetes and obesity. A recent study investigated whether and how overweight and/or diabetic psoriasis patients...…
View Post 5 min This content is machine translated Osteoporosis Risk-stratified therapy with osteoanabolic agents improves outcomes Patients with a very high or imminent fracture risk should be considered for (first-line) therapy with ostoanabolic substances. Both patient selection and planning of therapy sequences are decisive factors for...…
View Post 3 min This content is machine translated GLA:D® program for back pain patients Fewer consultations and reduction in the use of painkillers In a quasi-experimental Danish study of patients with lower back pain, participation in a structured self-management program led to a sustained reduction in the number of visits to the doctor...…
View Post 7 min This content is machine translated Evidence-based therapy for psoriasis in difficult locations IL-23 inhibition in scalp psoriasis: what’s new? Involvement of the scalp is common in psoriasis patients and can induce considerable distress with sometimes significant effects on quality of life. In addition to new study findings on the...…
View Post 4 min This content is machine translated Benralizumab in a patient with asthma and EGPA When the biologic has a counterproductive effect Eosinophilic vasculitis with polyangiitis (EGPA) is a rare inflammation of small blood vessels that is usually associated with asthma. Eye involvement occurs sporadically and central retinal artery occlusion (CRAO) is...…
View Post 5 min This content is machine translated Side effects under opioid therapy Is it possible to avoid the inevitable? Opioid analgesics are an essential tool for the relief of cancer-related pain. However, in addition to their undeniable therapeutic value, opioids are associated with a number of predictable side effects...…
View Post 4 min This content is machine translated Psoriatic arthritis Long-term remission also possible without DMARDs Remission without disease-modifying antirheumatic drugs has become an ambitious goal in inflammatory rheumatic diseases. While it has been extensively studied in rheumatoid arthritis, its feasibility in psoriatic arthritis (PsA) has...…
View Post 5 min This content is machine translated Early rheumatoid arthritis C1M has potential as a biomarker The earlier rheumatoid arthritis (RA) is diagnosed, the better the prognosis. But easier said than done. Conventional clinical, serological and imaging markers often lack sufficient sensitivity in the early stages...…
View Post 5 min This content is machine translated Study report: TBS v3 and v4 in comparison Analysis of OsteoLaus study data The OsteoLaus study is part of the prospective, population-based CoLaus/PsyColaus study of postmenopausal women in Switzerland. In an analysis published in Osteoporosis International in 2025, the Trabecular Bone Score (TBS)...…
View Post 10 min This content is machine translated Collagenoses Scleroderma – Current recommendations for diagnosis and therapy 2025 Early detection is critical for treatment options of this multisystem disease with cutaneous involvement. Raynaud’s attacks are often in early stages and should always be further evaluated. Advances in research...… CME-Test
View Post 9 min This content is machine translated Psoriasis: intervening in the inflammatory cascade Advantages of early biologic therapy and oral peptide as a beacon of hope The question of whether early biologics treatment can have a lasting effect on the course of psoriasis is the focus of numerous research projects. The GUIDE study investigated the corresponding...…
